
SBI Healthcare Opportunities Fund Direct Growth
SBI Healthcare Opportunities Fund Direct Growth
as on 06 Nov 2026
SBI Healthcare Opportunities Fund Direct Growth is a Equity mutual fund scheme launched on 01 Jan 2013. The current NAV stands at ₹608.2587 as of 06 Nov 2026. From the funds total AUM, its top holdings include Sun Pharmaceutical at 11.03%, Divis Laboratories at 6.57%, Acutaas Chemicals at 6.17%, Apollo Hospitals at 5.37%, Max Healthcare Institute at 4.76%
Scheme Overview
- Inception Date : 01 Jan 2013
- AUM : ₹5,870.00 Cr
- 5Y Returns (CAGR) : 19.81%
- Expense Ratio : 1.01%
- Min. SIP : ₹500
- Min. Lumpsum : ₹5,000
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
5Y
₹ 32.73 L
3.50%
₹ 36.98 L
8.00%
₹ 51.44 L
19.81%
Total Investment
₹ 30,00,000
Returns
₹ 21,44,303 (19.81%)
Maturity Value
₹ 51,44,303
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 5,870.00 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹5,870.00 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 88.67% | ||
| Basic Materials | 8.82% | ||
| Other | 2.51% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() S Sun Pharmaceutical | 11.03% | |
![]() D Divis Laboratories | 6.57% | |
![]() A Acutaas Chemicals | 6.17% | |
![]() A Apollo Hospitals | 5.37% | |
![]() M Max Healthcare Institute | 4.76% | |
![]() A Aurobindo Pharma | 3.90% | |
![]() A Aster DM Healthcare | 3.83% | |
![]() L Laurus Labs | 3.58% | |
![]() B Biocon | 3.52% | |
![]() T Torrent Pharmaceuticals | 3.48% | |
![]() F Fortis Healthcare | 3.05% | |
![]() A Anthem Biosciences | 3.00% | |
![]() G Gland Pharma | 2.96% | |
![]() M Mankind Pharma | 2.91% | |
![]() A Aether Industries | 2.65% | |
![]() J Jupiter Life Line Hospital | 2.62% | |
![]() S Sai Life Sciences | 2.54% | |
![]() T Treps | 2.48% | |
![]() S Sudeep Pharma | 2.21% | |
![]() L Lonza Group Ltd ADR | 2.14% | |
![]() A Alkem Laboratories | 2.11% | |
![]() K Krishna Institute of Medical Sciences | 1.99% | |
![]() L Lupin | 1.99% | |
![]() A Ajanta Pharma | 1.92% | |
![]() P Poly Medicure | 1.89% | |
![]() C Cipla | 1.84% | |
![]() C Cohance Lifesciences | 1.70% | |
![]() C Concord Biotech | 1.66% | |
![]() A Abbott | 1.47% | |
![]() G Global Health | 1.46% | |
![]() N Nephrocare Health Services | 1.05% | |
![]() R Rainbow Childrens Medicare | 0.91% | |
![]() D Dr. Lal Path Labs | 0.84% | |
![]() G Gufic BioSciences | 0.37% | |
![]() G GOI TBILL 364D-19/11/26 | 0.06% | |
![]() N Net Receivable / Payable | 0.03% | |
S Sanofi Consumer Healthcare | 0.00% | |
![]() M Medplus Health Services | 0.00% |
Fund Comparison
Fund Details
52W High NAV
₹ 611.0805
Min. SIP Amount
₹ 500.00
Min. Lumpsum Amount
₹ 5,000.00
AUM (in Cr.)
₹ 5,870.00
Expense Ratio
1.01%
Lock-in Period
No Lock in Period
52W Low NAV
₹ 462.8741
Inception Date
01 Jan 2013
Fund Age
13 Yrs
Benchmark
BSE Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit load of 0.50% if redeemed within 15 days
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Tanmaya Desai | B.E (Electronics),MBA Finance,C.F.A(USA) Level III Candidate. |
Fund Objective
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
SBI Mutual Fund
No. of Schemes
79
Total AUM
₹ 9,04,250.07 Cr
Contact Details
9th Floor,Crescenzo, C-39&39,G Block, Bandra kurla complex,Bandra (east), Mumbai-400 051.
Contact Details
9th Floor,Crescenzo, C-39&39,G Block, Bandra kurla complex,Bandra (east), Mumbai-400 051.
FAQs
When was SBI Healthcare Opportunities Fund launched?
What is the current NAV of SBI Healthcare Opportunities Fund?
What is the AUM of SBI Healthcare Opportunities Fund?
What is the rate of return of SBI Healthcare Opportunities Fund?
- In the past 1Y: 22.32%
- In the past 3Y: 25.30%
- In the past 5Y: 19.81%
What is the expense ratio of SBI Healthcare Opportunities Fund?
What is exit load of SBI Healthcare Opportunities Fund?
What is the portfolio of SBI Healthcare Opportunities Fund?
- Sun Pharmaceutical: 11.03%
- Divis Laboratories: 6.57%
- Acutaas Chemicals: 6.17%
- Apollo Hospitals: 5.37%
- Max Healthcare Institute: 4.76%
Top 3 sectoral holdings include:
- Healthcare: 88.67%
- Basic Materials: 8.82%
- Others: 2.57%
How risky is investing in SBI Healthcare Opportunities Fund?
Who is the fund manager SBI Healthcare Opportunities Fund?
What is the minimum investment required in SBI Healthcare Opportunities Fund?
How to invest in SBI Healthcare Opportunities Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App





































